Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
qingshen tiaozhi xiaoke tablets
- Development stage
- Unknown
- Lead developer
- Jiuxu Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Qingshen Tiaozhi Xiaoke Tablets (轻身调脂消渴片) is a 1.1-class innovative traditional Chinese medicine (TCM) developed by Jiangsu Jiuxu Pharmaceutical Group. It is an oral tablet formulation based on the classical TCM formula Xiao Xian Xiong Tang (小陷胸汤) from the *Shang Han Lun*. The drug is indicated for the treatment of metabolic syndrome and its associated conditions, including type 2 diabetes, hyperlipidemia, and hypertension, specifically targeting the phlegm-heat syndrome (痰热互结证) in TCM theory. Its pharmacological actions include lowering blood glucose, blood pressure, and blood lipids, as well as improving insulin resistance. In January 2026, the National Medical Products Administration (NMPA) accepted its Investigational New Drug (IND) application (trial number CXZL2600001), marking its entry into clinical development.
- Other names
- 轻身调脂消渴片Qingshen Tiaozhi Xiaoke Pian
Beyond the preview
Go deeper on qingshen tiaozhi xiaoke tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on qingshen tiaozhi xiaoke tablets.